Teerapat Ungtrakul

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial

Tassanee Sriprayoon, Chulabhorn Mahidol, Teerapat Ungtrakul et al. · Hepatology Research · 2016 · 57 citations

Medicine, Pharmacology, Pharmacotherapy +17

Andrographis paniculata: Dissolution investigation and pharmacokinetic studies of four major active diterpenoids after multiple oral dose administration in healthy Thai volunteers

Nanthanit Pholphana, Duangchit Panomvana, Nuchanart Rangkadilok et al. · Journal of Ethnopharmacology · 2016 · 36 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients

Yee Hui Yeo, Tai‐Chung Tseng, Tetsuya Hosaka et al. · Clinical and Translational Gastroenterology · 2020 · 34 citations · Full text

Medicine, Infectious Diseases, Epidemiologic Methods +12

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients

Matt Liu, Tai‐Chung Tseng, Dae Won Jun et al. · Hepatology International · 2021 · 33 citations

Medicine, Oncology, Cancer Epidemiology +14